The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial

The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial

Abstract Background Curing locally advanced gastric cancer through surgery alone is difficult. Adjuvant and neoadjuvant chemotherapy bring potential benefits to more patients with gastric cancer based on several clinical trials. According to phase II studies and guidelines, SOX regimen as neoadjuvan...

Full description

Bibliographic Details
Main Authors: Xinxin Wang, Shuo Li, Yihong Sun, Kai Li, Xian Shen, Yingwei Xue, Pin Liang, Guoli Li, Luchuan Chen, Qun Zhao, Guoxin Li, Weihua Fu, Han Liang, Hairong Xin, Jian Suo, Xuedong Fang, Zhichao Zheng, Zekuan Xu, Huanqiu Chen, Yanbing Zhou, Yulong He, Hua Huang, Linghua Zhu, Kun Yang, Jiafu Ji, Yingjiang Ye, Zhongtao Zhang, Fei Li, Xin Wang, Yantao Tian, Sungsoo Park, Lin Chen
Format: Article
Language:English
Published: BMC 2021-01-01
Series:BMC Cancer
Subjects:
Locally advanced gastric cancer
Duration of neoadjuvant chemotherapy
S-1
Oxaliplatin
Online Access:https://doi.org/10.1186/s12885-020-07764-7

Internet

https://doi.org/10.1186/s12885-020-07764-7

Similar Items